

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent Advances in Understanding Cholangiocarcinoma | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-1818/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-1818" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent Advances in Understanding Cholangiocarcinoma" />
    
            <meta name="og:title" content="F1000Research Article: Recent Advances in Understanding Cholangiocarcinoma.">
            <meta name="og:description" content="Read the latest article version by Lindsey Kennedy, Laura Hargrove, Jennifer Demieville, Nicole Francis, Rowan Seils, Sara Villamaria, Heather Francis, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="13116">
            <meta name="article-id" content="12118">
            <meta name="dc.title" content="Recent Advances in Understanding Cholangiocarcinoma">
            <meta name="dc.description" content="Cholangiocarcinoma (CCA) is an aggressive malignancy that arises from damaged epithelial cells, cholangiocytes, and possibly de-differentiated hepatocytes. CCA has a poor overall survival rate and limited therapeutic options. Based on this data, it is imperative that new diagnostic and therapeutic interventions be developed. Recent work has attempted to understand the pathological mechanisms driving CCA progression. Specifically, recent publications have delved into the role of cancer stem cells (CSCs), mesenchymal stem cells (MSCs), and microRNAs (miRNAs) during CCA pathology. CSCs are a specific subset of cells within the tumor environment that are derived from a cell with stem-like properties and have been shown to influence recurrence and chemoresistance during CCA. MSCs are known for their anti-inflammatory activity and have been postulated to influence malignancy during CCA, but little is known about their exact functions. miRNAs exert various functions via gene regulation at both the transcriptional and the translational levels, giving miRNAs diverse roles in CCA progression. Additionally, current miRNA-based therapeutic approaches are in clinical trials for various liver diseases, giving hope for similar approaches for CCA. However, the interactions among these three factors in the context of CCA are unknown. In this review, we focus on recently published data (within the last 3 years) that discuss the role of CSCs, MSCs, and miRNAs and their possible interactions during CCA pathogenesis.">
            <meta name="dc.subject" content="cholangiocarcinoma, microRNAs, cancer stem cells, mesenchymal stem cells">
            <meta name="dc.creator" content="Kennedy, Lindsey">
            <meta name="dc.creator" content="Hargrove, Laura">
            <meta name="dc.creator" content="Demieville, Jennifer">
            <meta name="dc.creator" content="Francis, Nicole">
            <meta name="dc.creator" content="Seils, Rowan">
            <meta name="dc.creator" content="Villamaria, Sara">
            <meta name="dc.creator" content="Francis, Heather">
            <meta name="dc.date" content="2017/10/09">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.12118.1">
            <meta name="dc.source" content="F1000Research 2017 6:1818">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="cholangiocarcinoma">
            <meta name="prism.keyword" content="microRNAs">
            <meta name="prism.keyword" content="cancer stem cells">
            <meta name="prism.keyword" content="mesenchymal stem cells">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/10/09">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="1818">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.12118.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-1818">
            <meta name="citation_title" content="Recent Advances in Understanding Cholangiocarcinoma">
            <meta name="citation_abstract" content="Cholangiocarcinoma (CCA) is an aggressive malignancy that arises from damaged epithelial cells, cholangiocytes, and possibly de-differentiated hepatocytes. CCA has a poor overall survival rate and limited therapeutic options. Based on this data, it is imperative that new diagnostic and therapeutic interventions be developed. Recent work has attempted to understand the pathological mechanisms driving CCA progression. Specifically, recent publications have delved into the role of cancer stem cells (CSCs), mesenchymal stem cells (MSCs), and microRNAs (miRNAs) during CCA pathology. CSCs are a specific subset of cells within the tumor environment that are derived from a cell with stem-like properties and have been shown to influence recurrence and chemoresistance during CCA. MSCs are known for their anti-inflammatory activity and have been postulated to influence malignancy during CCA, but little is known about their exact functions. miRNAs exert various functions via gene regulation at both the transcriptional and the translational levels, giving miRNAs diverse roles in CCA progression. Additionally, current miRNA-based therapeutic approaches are in clinical trials for various liver diseases, giving hope for similar approaches for CCA. However, the interactions among these three factors in the context of CCA are unknown. In this review, we focus on recently published data (within the last 3 years) that discuss the role of CSCs, MSCs, and miRNAs and their possible interactions during CCA pathogenesis.">
            <meta name="citation_description" content="Cholangiocarcinoma (CCA) is an aggressive malignancy that arises from damaged epithelial cells, cholangiocytes, and possibly de-differentiated hepatocytes. CCA has a poor overall survival rate and limited therapeutic options. Based on this data, it is imperative that new diagnostic and therapeutic interventions be developed. Recent work has attempted to understand the pathological mechanisms driving CCA progression. Specifically, recent publications have delved into the role of cancer stem cells (CSCs), mesenchymal stem cells (MSCs), and microRNAs (miRNAs) during CCA pathology. CSCs are a specific subset of cells within the tumor environment that are derived from a cell with stem-like properties and have been shown to influence recurrence and chemoresistance during CCA. MSCs are known for their anti-inflammatory activity and have been postulated to influence malignancy during CCA, but little is known about their exact functions. miRNAs exert various functions via gene regulation at both the transcriptional and the translational levels, giving miRNAs diverse roles in CCA progression. Additionally, current miRNA-based therapeutic approaches are in clinical trials for various liver diseases, giving hope for similar approaches for CCA. However, the interactions among these three factors in the context of CCA are unknown. In this review, we focus on recently published data (within the last 3 years) that discuss the role of CSCs, MSCs, and miRNAs and their possible interactions during CCA pathogenesis.">
            <meta name="citation_keywords" content="cholangiocarcinoma, microRNAs, cancer stem cells, mesenchymal stem cells">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Lindsey Kennedy">
            <meta name="citation_author_institution" content="Department of Internal Medicine, Texas A&amp;M Health Science Center, College of Medicine, Bryan, TX, USA">
            <meta name="citation_author_institution" content="Research, Central Texas Veterans Health Care System, Temple, TX, USA">
            <meta name="citation_author" content="Laura Hargrove">
            <meta name="citation_author_institution" content="Department of Internal Medicine, Texas A&amp;M Health Science Center, College of Medicine, Bryan, TX, USA">
            <meta name="citation_author" content="Jennifer Demieville">
            <meta name="citation_author_institution" content="Research, Central Texas Veterans Health Care System, Temple, TX, USA">
            <meta name="citation_author" content="Nicole Francis">
            <meta name="citation_author_institution" content="Baylor Scott &amp; White Health Digestive Disease Research Center, Temple, TX, USA">
            <meta name="citation_author" content="Rowan Seils">
            <meta name="citation_author_institution" content="Department of Internal Medicine, Texas A&amp;M Health Science Center, College of Medicine, Bryan, TX, USA">
            <meta name="citation_author" content="Sara Villamaria">
            <meta name="citation_author_institution" content="Department of Internal Medicine, Texas A&amp;M Health Science Center, College of Medicine, Bryan, TX, USA">
            <meta name="citation_author" content="Heather Francis">
            <meta name="citation_author_institution" content="Department of Internal Medicine, Texas A&amp;M Health Science Center, College of Medicine, Bryan, TX, USA">
            <meta name="citation_author_institution" content="Research, Central Texas Veterans Health Care System, Temple, TX, USA">
            <meta name="citation_author_institution" content="Baylor Scott &amp; White Health Digestive Disease Research Center, Temple, TX, USA">
            <meta name="citation_publication_date" content="2017/10/09">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="1818">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.12118.1">
            <meta name="citation_firstpage" content="1818">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-1818/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-1818.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=13116 /> <input type=hidden id=articleId name=articleId value=12118 /> <input type=hidden id=xmlUrl value="/articles/6-1818/v1/xml"/> <input type=hidden id=xmlFileName value="-6-1818-v1.xml"> <input type=hidden id=article_uuid value=e5938888-837a-4e94-9179-7cb26f6856b8 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent Advances in Understanding Cholangiocarcinoma"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.12118.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.12118.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-1818"
  },
  "headline": "Recent Advances in Understanding Cholangiocarcinoma",
  "datePublished": "2017-10-09T14:27:05",
  "dateModified": "2017-10-09T14:27:05",
  "author": [
    {
      "@type": "Person",
      "name": "Lindsey Kennedy"
    },    {
      "@type": "Person",
      "name": "Laura Hargrove"
    },    {
      "@type": "Person",
      "name": "Jennifer Demieville"
    },    {
      "@type": "Person",
      "name": "Nicole Francis"
    },    {
      "@type": "Person",
      "name": "Rowan Seils"
    },    {
      "@type": "Person",
      "name": "Sara Villamaria"
    },    {
      "@type": "Person",
      "name": "Heather Francis"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Cholangiocarcinoma (CCA) is an aggressive malignancy that arises from damaged epithelial cells, cholangiocytes, and possibly de-differentiated hepatocytes. CCA has a poor overall survival rate and limited therapeutic options. Based on this data, it is imperative that new diagnostic and therapeutic interventions be developed. Recent work has attempted to understand the pathological mechanisms driving CCA progression. Specifically, recent publications have delved into the role of cancer stem cells (CSCs), mesenchymal stem cells (MSCs), and microRNAs (miRNAs) during CCA pathology. CSCs are a specific subset of cells within the tumor environment that are derived from a cell with stem-like properties and have been shown to influence recurrence and chemoresistance during CCA. MSCs are known for their anti-inflammatory activity and have been postulated to influence malignancy during CCA, but little is known about their exact functions. miRNAs exert various functions via gene regulation at both the transcriptional and the translational levels, giving miRNAs diverse roles in CCA progression. Additionally, current miRNA-based therapeutic approaches are in clinical trials for various liver diseases, giving hope for similar approaches for CCA. However, the interactions among these three factors in the context of CCA are unknown. In this review, we focus on recently published data (within the last 3 years) that discuss the role of CSCs, MSCs, and miRNAs and their possible interactions during CCA pathogenesis."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-1818",
            "name": "Recent Advances in Understanding Cholangiocarcinoma"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent Advances in Understanding Cholangiocarcinoma </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=13116 data-id=12118 data-downloads="" data-views="" data-scholar="10.12688/f1000research.12118.1" data-recommended="" data-doi="10.12688/f1000research.12118.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-1818/v1/pdf?article_uuid=e5938888-837a-4e94-9179-7cb26f6856b8" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-12118-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-12118-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-12118-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Kennedy L, Hargrove L, Demieville J <em>et al.</em> Recent Advances in Understanding Cholangiocarcinoma [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1818 (<a class=new-orange href="https://doi.org/10.12688/f1000research.12118.1" target=_blank>https://doi.org/10.12688/f1000research.12118.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-12118-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=12118 id=track-article-signin-12118 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/12118?target=/articles/6-1818">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=13116 /> <input name=articleId type=hidden value=12118 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent Advances in Understanding Cholangiocarcinoma</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Lindsey Kennedy<sup>1,2</sup>,&nbsp;</span><span class="">Laura Hargrove<sup>1</sup>,&nbsp;</span><span class="">Jennifer Demieville<sup>2</sup>,&nbsp;</span><a href="#" class=article-page-expand-authors>[...]&nbsp;</a><span class=article-page-hidden-authors>Nicole Francis<sup>3</sup>,&nbsp;</span><span class="">Rowan Seils<sup>1</sup>,&nbsp;</span><span class="">Sara Villamaria<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:HFrancis@medicine.tamhsc.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Heather Francis</span></a><a href="https://orcid.org/0000-0001-5428-641X" target=_blank id=author-orcid-6><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-6><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-5428-641X</div><sup>1-3</sup></span><span class="author-display-control article-page-expand-authors f1r-icon icon-20_plus_big"></span><span class="author-display-control article-page-hidden-authors f1r-icon icon-12_minus_big"></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Lindsey Kennedy<sup>1,2</sup>,&nbsp;</span><span class="">Laura Hargrove<sup>1</sup>,&nbsp;</span><a href="#" class=article-page-expand-authors>[...]&nbsp;</a><span class=article-page-hidden-authors>Jennifer Demieville<sup>2</sup>,&nbsp;</span><span class=article-page-hidden-authors>Nicole Francis<sup>3</sup>,&nbsp;</span><span class=article-page-hidden-authors>Rowan Seils<sup>1</sup>,&nbsp;</span><span class="">Sara Villamaria<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:HFrancis@medicine.tamhsc.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Heather Francis</span></a><a href="http://orcid.org/0000-0001-5428-641X" target=_blank id=mauthor-orcid-6><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-6><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-5428-641X</div><sup>1-3</sup></span><span class="author-display-control article-page-expand-authors f1r-icon icon-20_plus_big"></span><span class="author-display-control article-page-hidden-authors f1r-icon icon-12_minus_big"></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 09 Oct 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.12118.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Internal Medicine, Texas A&amp;M Health Science Center, College of Medicine, Bryan, TX, USA<br/> <sup>2</sup> Research, Central Texas Veterans Health Care System, Temple, TX, USA<br/> <sup>3</sup> Baylor Scott &amp; White Health Digestive Disease Research Center, Temple, TX, USA<br/> <p> <div class=margin-bottom> Lindsey Kennedy <br/> <span>Roles: </span> Conceptualization, Resources, Supervision, Validation, Writing  Review & Editing </div> <div class=margin-bottom> Laura Hargrove <br/> <span>Roles: </span> Conceptualization, Investigation, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Jennifer Demieville <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> Nicole Francis <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> Rowan Seils <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> Sara Villamaria <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> Heather Francis <br/> <span>Roles: </span> Writing  Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=26935-26798></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=26936-26799></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Cholangiocarcinoma (CCA) is an aggressive malignancy that arises from damaged epithelial cells, cholangiocytes, and possibly de-differentiated hepatocytes. CCA has a poor overall survival rate and limited therapeutic options. Based on this data, it is imperative that new diagnostic and therapeutic interventions be developed. Recent work has attempted to understand the pathological mechanisms driving CCA progression. Specifically, recent publications have delved into the role of cancer stem cells (CSCs), mesenchymal stem cells (MSCs), and microRNAs (miRNAs) during CCA pathology. CSCs are a specific subset of cells within the tumor environment that are derived from a cell with stem-like properties and have been shown to influence recurrence and chemoresistance during CCA. MSCs are known for their anti-inflammatory activity and have been postulated to influence malignancy during CCA, but little is known about their exact functions. miRNAs exert various functions via gene regulation at both the transcriptional and the translational levels, giving miRNAs diverse roles in CCA progression. Additionally, current miRNA-based therapeutic approaches are in clinical trials for various liver diseases, giving hope for similar approaches for CCA. However, the interactions among these three factors in the context of CCA are unknown. In this review, we focus on recently published data (within the last 3 years) that discuss the role of CSCs, MSCs, and miRNAs and their possible interactions during CCA pathogenesis. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> cholangiocarcinoma, microRNAs, cancer stem cells, mesenchymal stem cells </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Heather Francis (<a href="mailto:HFrancis@medicine.tamhsc.edu">HFrancis@medicine.tamhsc.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Heather Francis </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> Portions of this work were supported by (i) a VA Merit Award (1I01BX003031) from the US Department of Veterans Affairs, Biomedical Laboratory Research and Development Service and (ii) the National Institute of Health National Institute of Diabetes and Digestive and Kidney Diseases (DK108959). This material is the result of work supported with resources and the use of facilities at the Central Texas Veterans Health Care System (Temple, TX, USA). The content is the responsibility of the authors alone and does not necessarily reflect the views or policies of the Department of Veterans Affairs or the US Government. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2017 Kennedy L <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Kennedy L, Hargrove L, Demieville J <em>et al.</em> Recent Advances in Understanding Cholangiocarcinoma [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1818 (<a href="https://doi.org/10.12688/f1000research.12118.1" target=_blank>https://doi.org/10.12688/f1000research.12118.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 09 Oct 2017, <b>6</b>(F1000 Faculty Rev):1818 (<a href="https://doi.org/10.12688/f1000research.12118.1" target=_blank>https://doi.org/10.12688/f1000research.12118.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 09 Oct 2017, <b>6</b>(F1000 Faculty Rev):1818 (<a href="https://doi.org/10.12688/f1000research.12118.1" target=_blank>https://doi.org/10.12688/f1000research.12118.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d58620e255>Introduction</h2><p class="" id=d58620e258>Cholangiocarcinoma (CCA) is a hepatobiliary malignancy with a poor 5-year survival rate and limited treatment options. CCA arises from damaged cholangiocytes, the epithelial cells that line the biliary tree. CCA can be classified into intrahepatic, perihilar, or distal subtypes<sup><a href="#ref-1">1</a></sup>. Intrahepatic CCA, the second most common form of liver cancer, is generally located proximal to the second-order bile ducts, perihilar CCA is located between the second-order bile ducts and the intersection of the cystic duct into the common bile duct, and distal CCA is found in areas between the cystic duct and the ampulla of Vater (<a href="#f1">Figure 1</a>)<sup><a href="#ref-2">2</a></sup>. Aside from being categorized by anatomic location, CCA is categorized on the basis of histopathological analysis and by growth-type patterns as well<sup><a href="#ref-3">3</a>,<a href="#ref-4">4</a></sup>. For instance, CCA that has been derived from large cholangiocytes is predominantly categorized as perihilar CCA with well to moderately differentiated mucin-producing cells and periductal infiltrating growth pattern, whereas CCA that is derived from small cholangiocytes is predominantly categorized as intrahepatic CCA and largely contains nonmucin-producing cells and has mass-forming growth patterns<sup><a href="#ref-3">3</a>,<a href="#ref-4">4</a></sup>. CCA is highly heterogeneous not only in initiation and location but also in progression, making it difficult to categorize CCA into distinct subtypes.</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/13116/0303aba0-f0be-4ed9-bc51-9dbe1a0af628_figure1.gif"><img alt="0303aba0-f0be-4ed9-bc51-9dbe1a0af628_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/13116/0303aba0-f0be-4ed9-bc51-9dbe1a0af628_figure1.gif"></a><div class=caption><h3>Figure 1. Schematic image of the anatomical locations of intrahepatic, perihilar, and distal cholangiocarcinoma (CCA).</h3><p id=d58620e296>CCA is categorized on the basis of its location within the biliary tree. Intrahepatic CCA is found proximal to the second-order bile ducts, perihilar CCA is found between the second-order bile ducts and the convergence of the cystic duct and the common duct, and distal CCA is found between the cystic duct and ampulla of Vater.</p></div></div><p class="" id=d58620e303>CCA incidence has been steadily increasing<sup><a href="#ref-5">5</a></sup>. One of the first lines of treatment for CCA is resection; however, options for resection are limited since the disease is generally too advanced at the time of diagnosis<sup><a href="#ref-6">6</a></sup>. Recently, it has been reported that following resection in patients with intrahepatic CCA the 5-year and 10-year survival rates are 32.3% and 8.4%, respectively<sup><a href="#ref-7">7</a></sup>. If unresectable, liver transplantation is another option for patients with intrahepatic CCA, and post-liver transplantation 5-year survival rates are 51%<sup><a href="#ref-8">8</a></sup>. For patients with perihilar CCA, resection may be an option but outcomes are poor; 5-year survival rates are 10%<sup><a href="#ref-9">9</a></sup>. It has also been suggested that some subsets of perihilar CCA may benefit from neoadjuvant chemoradiation therapy or biliary drainage or both, but outcomes are variable<sup><a href="#ref-10">10</a><a href="#ref-12">12</a></sup>. For patients with distal CCA following resection, 5-year survival rates are 23%<sup><a href="#ref-9">9</a></sup>. Furthermore, these patients should not be subjected to biliary drainage, since they tend to have increased complications related to this surgery<sup><a href="#ref-13">13</a></sup>. It is apparent that our current approaches for CCA are lacking, as demonstrated by the poor survival rates and limited treatment options. For these reasons, it is critical that new and effective therapies be developed.</p><p class="" id=d58620e342>The CCA microenvironment contains a plethora of cell types, extracellular structures, and secreted factors that influence the progression of the tumor. Cancer cells are surrounded by stroma, which is made up of various stromal cells and extracellular matrix<sup><a href="#ref-14">14</a></sup>. Additionally, cytokines, chemokines, growth factors, and proteinases secreted from cancer cells and stromal cells can promote a pro-inflammatory environment<sup><a href="#ref-14">14</a></sup>. This type of tumor microenvironment can lead to myofibroblast activation, cancer stem cell (CSC) initiation, and the recruitment of various inflammatory cell types<sup><a href="#ref-14">14</a></sup>. The CCA microenvironment is a complex network that is influenced by a multitude of soluble factors and cell types.</p><p class="" id=d58620e358>This review will focus on recent publications (within the last 3 years) that advance our understanding of CCA and will analyze how their findings could lead to new diagnostic or therapeutic targets. Overall, these publications discuss their findings within the context of all three subtypes of CCA (intrahepatic, perihilar, and distal), and for this reason we discuss the findings of the articles in the context of general CCA. Among the recent publications, many of the articles fell into similar categories. Specifically, publications tended to focus on the functional and mechanistic roles of (i) CSCs, (ii) mesenchymal stem cells (MSCs), or (iii) microRNAs (miRNAs) in CCA progression. We will be discussing how these three categories influence the CCA microenvironment, either alone or in relation to one another.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d58620e364>Cancer stem cells</h2><p class="" id=d58620e367>The tumor microenvironment comprises many different cell types with various functions. Recently, CSCs have been identified in the tumor microenvironment and add complexity to our understanding of CCA. Specifically, CSCs have been identified for their role in tumor initiation, progression, and relapse. CSCs function in a manner similar to normal stem cells, wherein they are capable of self-renewal, can differentiate into multiple different cell types, and have unlimited division<sup><a href="#ref-15">15</a></sup>. CSCs promote an inflammatory environment through the activation of stromal cells and the recruitment of inflammatory cells<sup><a href="#ref-16">16</a></sup>. The cell type from which CSCs are derived is still under debate, but it has been hypothesized that CSCs may be derived from a stem-like cell that acquires a cancer-promoting alteration<sup><a href="#ref-17">17</a></sup>. Multiple studies have found that hepatocellular carcinoma (HCC) progression is driven by CSCs<sup><a href="#ref-18">18</a><a href="#ref-21">21</a></sup>; however, little is known about the role of CSCs in CCA.</p><p class="" id=d58620e389>As previously stated, the CCA microenvironment is a complex network of various cell types. Among the various cell types, macrophages are associated with CCA tumor progression and are significantly correlated with a poorer prognosis and metastasis<sup><a href="#ref-4">4</a></sup>. A recent article by Raggi <i>et al</i>. hypothesized that CSCs secrete factors that promote macrophage differentiation toward the tumor-associated macrophage (TAM) subtype<sup><a href="#ref-22">22</a></sup>. First, CCA spheres were cultured and medium was collected and placed on cultured macrophages. Following treatment with CCA sphere medium, macrophages expressed cluster of differentiation 68 (CD68), CD115, human leukocyte antigen-D related, and CD206, indicating an activated phenotype. These activated macrophages had TAM-like features, including increased invasiveness. To identify whether these findings were clinically relevant, macrophages were isolated from human CCA resections, and it was noted that these isolated macrophages expressed a phenotype similar to that of the treated cultured macrophages. The authors then identified the factors secreted from CCA spheres that were driving this TAM-like phenotype and found that interleukin-13 (IL-13), IL-34, and osteoactivin were detected in CCA sphere medium and in serum of patients with CCA. Furthermore, these factors were associated with CSC presence, and the authors concluded that the secreted factors driving the TAM-like phenotype must be derived from CSCs. These findings present a novel mechanism by which CCA-associated CSCs influence the activation of TAMs that promote CCA progression<sup><a href="#ref-22">22</a></sup>. Given that much of the work was done with CCA sphere medium, more work regarding the exact factors secreted from CSCs is necessary to definitively demonstrate that the activation of TAMs is specifically driven by CSCs.</p><p class="" id=d58620e407>Laminins are a family of extracellular matrix proteins that are mainly found in the basement membrane and are composed of , , and  chains<sup><a href="#ref-23">23</a>,<a href="#ref-24">24</a></sup>. The 2-chain of laminin-332 (Ln-332) is highly elevated in HCCs expressing the biliary marker cytokeratin-19 (CK-19) and is correlated with a poor prognosis for patients with HCC or intrahepatic CCA<sup><a href="#ref-25">25</a><a href="#ref-27">27</a></sup>. The aim of the publication by Govaere <i>et al</i>. was to characterize the CSC niche and determine the possible cell of origin<sup><a href="#ref-28">28</a></sup>. This publication slightly deviates from the others discussed in this review because it looks at CSCs in mixed HCC/CCA samples. It was noted that elevated biliary and hepatic progenitor cell (HPC) markers were seen with increased expression of <i>LAMC2</i>, the gene that encodes the 2-chain of Ln-332. Immunopositivity for the 2-chain of Ln-332 was found surrounding small HPC-like tumor cells that had a low proliferation rate, identified as possible CSCs. Lastly, the 2-chain of Ln-332 was strongly co-expressed in ductular areas with low proliferative capacity but was expressed at low levels in the hepatocyte areas of HCC/CCA. The authors concluded that Ln-332 maintains the CSC niche and supports stem-like properties in these cells<sup><a href="#ref-28">28</a></sup>. While this article is one of a few that looks at the factors that maintain CSCs, future work needs to be performed to look at the role of Ln-332 specifically in CCA samples.</p><p class="" id=d58620e439>Given these findings, it is evident that the formation of CSCs strongly impacts the surrounding tumor microenvironment, which can impact disease progression. Specifically, these articles identify the pro-inflammatory role of CSCs during CCA. First, CSCs were shown to promote macrophage transition to a TAM-like phenotype. Furthermore, CSC accumulation of laminins, a key component of extracellular matrix, may promote the survival, migration, and invasion of tumor cells as well as stromal activation. It is evident that CSCs are key in maintaining and promoting a pro-inflammatory environment during CCA initiation and progression.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d58620e445>Mesenchymal stem cells</h2><p class="" id=d58620e448>Recently, interest in the role of MSCs in tumor progression and metastasis has increased. MSCs are non-hematopoietic stem cells that primarily reside in the bone marrow but are recruited to injured tissues, inflammatory sites, and primary tumors<sup><a href="#ref-29">29</a><a href="#ref-31">31</a></sup>. As stated above, the presence of CSCs promotes an inflammatory environment, which may promote MSC migration and the infiltration of CCA tumors. MSCs have low immunogenicity and, following recruitment to injured tissues, are able to maintain their multi-differentiation capacity<sup><a href="#ref-32">32</a></sup>. Specifically, MSCs may differentiate into cancer-associated fibroblasts, myofibroblasts, or hepatic stellate cells to promote tumor progression<sup><a href="#ref-33">33</a>,<a href="#ref-34">34</a></sup>. These various cell types increase the inflammatory capacity of the stromal environment, further promoting the initiation of CSCs and the recruitment of MSCs. Moreover, MSCs secrete various cytokines that promote an inflammatory microenvironment<sup><a href="#ref-35">35</a>,<a href="#ref-36">36</a></sup>. For these reasons, the role of MSCs in CCA progression and inflammatory response has become a topic of interest.</p><p class="" id=d58620e476>While MSCs are known to influence the inflammatory environment of tumors, the exact microenvironment necessary for these effects is unknown. Also, it has been postulated that inflammatory conditions are a major activator of MSC-associated immunosuppression<sup><a href="#ref-37">37</a></sup>. Recent work from Zhong <i>et al</i>. found that tumor necrosis factor-alpha (TNF-) and interferon-gamma (IFN-) were able to stimulate the expression of TNF-, C-C motif chemokine ligand 5 (CCL5), IL-6 and indoleamine 2,3-dioxygenase, and activated nuclear factor kappa B (NF-B) signaling in MSCs<sup><a href="#ref-38">38</a></sup>. Secreted factors from these stimulated MSCs were able to induce CCA cell migration and metastasis <i>in vitro</i> and <i>in vivo</i>. Furthermore, CCA cells treated with supernatants from the stimulated MSCs had increased expression of C-C motif chemokine receptor 5 (CCR5). Increased CCL5/CCR5 signaling in CCA cells was able to increase the expression of matrix metalloproteinase-2 (MMP-2) and MMP-9. Overall, the authors deduced that TNF- and IFN- stimulate MSCs to secrete CCL5, which in turn activates CCR5 on CCA cells to promote inflammation and metastasis<sup><a href="#ref-38">38</a></sup>. Inhibition of TNF- or IFN- signaling or both could block MSC recruitment, thereby reducing CCA inflammation and metastasis to hopefully contribute to an improved outcome.</p><p class="" id=d58620e501>Chemoresistance is a major obstacle in cancer treatment. Previously, it was demonstrated that MSC-secreted IL-8 induces doxorubicin resistance in triple-negative breast cancer<sup><a href="#ref-39">39</a></sup>. Considering these findings, Wang <i>et al</i>. examined the role of MSCs in the progression of CCA development<sup><a href="#ref-40">40</a></sup>. Using human umbilical cordderived MSCs, the authors noted that cultured CCA cells that were co-cultured with these MSCs had increased cell proliferation, metastasis, and resistance to the anti-cancer drug compound K <i>in vivo</i>. <i>In vitro</i>, CCA cells co-cultured with MSCs had increased colony formation and invasion. The tumors from mice injected with CCA cells co-cultured with MSCs demonstrated enhanced Wnt/-catenin signaling. These findings were corroborated <i>in vitro</i> where MSCs and their secreted factors were shown to stimulate Wnt signaling via nuclear translocation of -catenin, upregulation of Wnt, and increased expression of the downstream targets MMP-2, cyclin D1, and c-Myc in cultured CCA cells. Overall, this study indicates that MSCs increase CCA metastasis and chemoresistance via increased Wnt/-catenin signaling<sup><a href="#ref-40">40</a></sup>. Targeting the Wnt/-catenin signaling pathway may prove therapeutic for patients with CCA.</p><p class="" id=d58620e529>It is interesting to note that TNF- and IFN- are necessary to drive MSC migration to CCA tumors. Given that CSCs promote an inflammatory environment, this may play a role in the recruitment of MSCs to the CCA tumor. Based on these articles, the presence of MSCs in CCA is indicative of increased CCA migration and invasion, and inhibition of MSC migration or induction of MSC apoptosis may be therapeutic for patients with CCA.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d58620e535>microRNAs</h2><p class="" id=d58620e538>miRNAs are short, non-coding RNAs that regulate the expression of specific mRNAs<sup><a href="#ref-41">41</a></sup>. Specifically, miRNAs will recognize and bind to complementary sequences found within the 3 untranslated region (3 UTR) of specific mRNAs to regulate their expression levels<sup><a href="#ref-42">42</a>,<a href="#ref-43">43</a></sup>. The role of miRNAs varies, depending on the cellular process, in both physiological and pathological conditions<sup><a href="#ref-44">44</a><a href="#ref-46">46</a></sup>. The function of miRNAs during CCA has increasingly become a topic of interest; multiple human clinical trials evaluating the efficacy of miRNA-based therapeutics during various liver diseases are under way<sup><a href="#ref-47">47</a>,<a href="#ref-48">48</a></sup>. miRNA signaling has been noted in all three subtypes of CCA<sup><a href="#ref-49">49</a><a href="#ref-51">51</a></sup>; however, the identification of subtype-specific miRNAs has not been made. It is known that miRNAs can regulate MSC and CSC function<sup><a href="#ref-52">52</a><a href="#ref-54">54</a></sup>, but this regulation has not been reported in the context of CCA. Further understanding the impact of miRNAs on CCA development and progression may bring about novel diagnostic tools or therapeutic interventions. In this section, we will be discussing the role of miRNAs during CCA progression but also analyzing their potential impacts on CSC and MSC biology.</p><p class="" id=d58620e581>Menin is a known tumor-suppressor gene that is expressed in all tissues<sup><a href="#ref-55">55</a></sup>, but its role in CCA is poorly defined. miR-24 has previously been recognized as an oncogene in multiple gastrointestinal cancers and has been shown to target menin, but this interaction in the context of CCA is not understood<sup><a href="#ref-56">56</a><a href="#ref-59">59</a></sup>. A recent article by Ehrlich <i>et al</i>. evaluated the role of menin during CCA proliferation and angiogenesis and its regulation by miR-24<sup><a href="#ref-51">51</a></sup>. The authors found that human advanced CCA tumor sections, as well as <i>in vitro</i> human CCA cell lines, had increased miR-24 expression alongside decreased menin expression. <i>In vitro</i>, human CCA cell lines treated with an miR-24 inhibitor showed increased menin levels with a subsequent reduction in cell proliferation, angiogenesis, migration, and invasion. It was then demonstrated that miR-24 negatively regulates menin expression. <i>In vivo</i>, the authors noted that tumor size and the expression of proliferative and angiogenic markers were significantly reduced in the miR-24inhibited tumor group compared with controls. Interestingly, fibrogenesis was enhanced in the miR-24inhibited tumor group when compared with controls. From this study, it is evident that miR-24 acts as an oncogene to suppress menin expression, thereby increasing tumor burden, proliferation, angiogenesis, migration, and invasion<sup><a href="#ref-51">51</a></sup>. However, further work is necessary to delineate the exact downstream mechanisms regulating these events as well as understand the primary cellular source of miR-24 during CCA, which may help us understand why fibrogenesis increased even as tumor burden and angiogenesis decreased. While this study focuses on the role of miR-24 in cultured CCA cells, miR-24 has previously been shown to promote stemness in embryonic stem cells<sup><a href="#ref-60">60</a></sup>. In this context, miR-24 may promote the formation of CSCs in CCA, leading to increased CCA migration and invasion.</p><p class="" id=d58620e620>Circadian rhythms are endogenous oscillations that are regulated by clock genes and are present in the central nervous system, peripheral tissues, and single cells<sup><a href="#ref-61">61</a></sup>. While circadian oscillations are a normal physiological process, dysregulation of these oscillations promotes tumor development<sup><a href="#ref-62">62</a>,<a href="#ref-63">63</a></sup>; however, little is known about the role of the circadian rhythm during CCA. A recent publication identified that the expression of Per1, which negatively regulates circadian oscillations, was decreased in human CCA samples and cultured human CCA cell lines<sup><a href="#ref-64">64</a></sup>. In addition, overexpression of Per1 decreased cell proliferation and increased apoptosis in cultured human CCA cells. These findings were mimicked <i>in vivo</i>, wherein immunocompromised mice injected with cultured human CCA cells overexpressing Per1 had decreased tumor growth, proliferation, angiogenesis, and metastasis. Per1 was found to be a target of miR-34a, and following treatment with a miR-34a inhibitor, human cultured CCA cells had decreased proliferation, migration, and invasion. These findings are the first to identify that the disruption of clock genes regulated by miR-34a contributes to CCA malignancy<sup><a href="#ref-64">64</a></sup>. As stated, circadian clock genes are present in all cells and tissues, and previous work has shown that circadian clock genes regulate MSC differentiation, migration, and cell cycle<sup><a href="#ref-65">65</a></sup>. It is possible that the regulation of core clock genes via miR-34a plays a role in MSC migration and activation during CCA. Also, the disruption of core clock genes in CCA cells may contribute to the tumor niche, thereby supporting CSC formation or MSC recruitment or both.</p><p class="" id=d58620e650>Tumor growth and metastatic potential are regulated by a myriad of factors, including epigenetic changes, such as DNA methylation<sup><a href="#ref-66">66</a>,<a href="#ref-67">67</a></sup>. Specifically, it has been shown that DNA methylation plays a prominent role in the progression of CCA<sup><a href="#ref-68">68</a></sup>. On the basis of this information, Zhou <i>et al</i>. set out to investigate the functional and mechanistic role of miR-191 in CCA<sup><a href="#ref-69">69</a></sup>. It was first noted that miR-191 expression was increased in CCA tumors when compared with adjacent normal bile duct tissue. miR-191 expression was found to be an independent risk factor for a worse prognosis for human CCA patients. <i>In vivo</i> and <i>in vitro</i> analysis revealed that overexpression of miR-191 was associated with enhanced proliferation, invasion, and migration and reduced ten-eleven translocation 1 (TET1) expression, which induces DNA demethylation and was shown to be a direct target of miR-191. The authors then found that TET1 expression allows for the methylation of CpG-rich regions in the gene transcription start site of p53, a tumor suppressor, leading to a reduction of p53 expression and subsequent increase in tumor burden. These findings suggest that the overexpression of miR-191 is associated with CCA progression via miR-191/TET1/p53 signaling<sup><a href="#ref-69">69</a></sup>. Aside from its role in p53 expression<sup><a href="#ref-70">70</a></sup>, miR-191 has been shown to promote CSC-like properties in bronchial epithelial cells, alluding to the fact that miR-191 may influence the CSC niche in CCA as well. This publication identifies a novel therapeutic target for the treatment of CCA and suggests that miR-191 levels may be used as a diagnostic or prognostic factor or both.</p><p class="" id=d58620e687>Aside from p53, N-myc downstream-regulated gene 2 (NDRG2) is another tumor suppressor that plays a role in the progression of various cancers<sup><a href="#ref-71">71</a>,<a href="#ref-72">72</a></sup>. NDRG2 has been shown to be downregulated during tumor progression, and it has been postulated that NDRG2 inhibits the metastasis of HCC<sup><a href="#ref-71">71</a><a href="#ref-73">73</a></sup>. miR-181 is upregulated in several cancers<sup><a href="#ref-74">74</a><a href="#ref-76">76</a></sup>; however, miR-181 has also been shown to inhibit tumor formation<sup><a href="#ref-77">77</a><a href="#ref-79">79</a></sup>. Leukemia inhibitory factor (LIF) is a member of the IL-6 cytokine family whose dysregulation has been observed in different cancers<sup><a href="#ref-79">79</a></sup>. The potential function of NDRG2, LIF, and miR-181c in the development and progression of CCA is not fully understood, and a recent publication evaluated the potential roles and mechanisms of these factors<sup><a href="#ref-80">80</a></sup>. The authors found that the expression of NDRG2 was decreased and miR-181c and LIF increased in human CCA compared with non-tumor tissues. Furthermore, downregulation of NDRG2 alongside overexpression of miR-181c or LIF indicated a poorer overall survival in patients with CCA. <i>In vivo</i> and <i>in vitro</i>, it was shown that overexpression of NDRG2 was able to inhibit CCA cell proliferation, chemoresistance, and metastasis. LIF was able to activate miR-181c, while NDRG2 inhibited LIF transcription. These findings identify that NDRG2 and LIF/miR-181c counteract each other, and dysregulation of one of these pathways may contribute to carcinogenesis and metastasis<sup><a href="#ref-80">80</a></sup>. Given that LIF is an IL-6 cytokine, miR-181c regulation of LIF may influence the inflammatory properties of the microenvironment so that it favors CSC formation or MSC recruitment. Though complex, this novel pathway may serve as a potential therapeutic target for the treatment of CCA.</p><p class="" id=d58620e737>The role of miR-16 in tumorigenesis has been studied in various cancers<sup><a href="#ref-81">81</a><a href="#ref-83">83</a></sup>, but its role in CCA is unknown. Yes-associated protein 1 (YAP1) is inhibited by the hippo signaling pathway, but in the absence of this inhibition, YAP1 acts as an oncogene in numerous cancers<sup><a href="#ref-84">84</a><a href="#ref-88">88</a></sup>; however, mechanisms regulating YAP1 expression in human CCA are largely unknown. Recent work found that in human CCA tissues miR-16 expression was significantly downregulated and correlated with tumor size, metastasis, and staging<sup><a href="#ref-89">89</a></sup>. Furthermore, downregulation of miR-16 was strongly associated with increased tumor progression and worsened overall survival in human CCA patients. <i>In vivo</i> and <i>in vitro</i> experimentation demonstrated that overexpression of miR-16 inhibited CCA cell proliferation, invasion, and metastasis. The authors then found that YAP1 was a direct target of miR-16. In support of these findings, it was noted that YAP1 levels are greatly enhanced in human CCA tissues, which was inversely correlated with the above findings that miR-16 is largely downregulated in human CCA. This publication concludes that miR-16 acts as a tumor suppressor in CCA through downregulation of YAP1<sup><a href="#ref-89">89</a></sup>. The miR-16/YAP1 interaction may not only be a therapeutic target but also act as a reliable prognostic marker for CCA. Additionally, YAP1 has been shown to control the self-renewal and differentiation of MSCs; therefore, miR-16 regulation of YAP1 may influence MSC function during CCA<sup><a href="#ref-90">90</a></sup>.</p><p class="" id=d58620e773>It has long been known that miRNAs play a role in the initiation and progression of CCA, but miRNA regulation of MSCs and CSCs during CCA is unknown. While these publications discuss the role of miRNAs in CCA cells and tissues, we can draw comparisons to the impact that they may have on MSC and CSC function. Furthermore, we can note that miRNA signaling may manipulate the microenvironment to become pro-inflammatory, which will favor the initiation of CSC formation as well as the recruitment of MSCs to the injured tissue. However, the discussion of miRNA regulation of MSCs and CSCs during CCA is largely speculative, and further research is necessary to fully understand this signaling process.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d58620e779>Conclusions</h2><p class="" id=d58620e782>Currently, therapeutic options for patients with CCA are extremely limited, a worrying predicament given the increase in incidence. In addition, options for patients with CCA are further limited since the disease tends to be at an advanced stage at the time of diagnosis. These facts indicate the imperative need to develop better diagnostic tools to help identify CCA at an earlier time point as well as more sophisticated therapeutic tools to improve survival rates. The roles of MSCs and CSCs during CCA are a new area of study with little information known about these cells. For this reason, more studies are needed to fully elucidate the impact that MSCs and CSCs have on CCA development and progression. It is possible that therapies targeting these cells will reduce chemoresistance and recurrence, but only future studies will be able to fully define this. There are a large number of publications regarding miRNA regulation of CCA progression; however, miRNA regulation of MSCs and CSCs during CCA is unknown. Given that miRNA therapies for various liver diseases are currently in clinical trials, there is hope that new miRNA-based therapies are developed for CCA, specifically those that may impact MSC and CSC function. While we have made strides in terms of understanding the CCA tumor environment and the pathways regulating progression, few translational findings have been developed. In the future, translational studies are necessary to help find diagnostic, prognostic, and therapeutic tools for the treatment of CCA.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d58620e789>Abbreviations</h2><p class="" id=d58620e792>CCA, cholangiocarcinoma; CCL5, C-C motif chemokine ligand 5; CCR5, C-C motif chemokine receptor 5; CD, cluster of differentiation; CSC, cancer stem cell; HCC, hepatocellular carcinoma; HPC, hepatic progenitor cell; IFN-, interferon-gamma; IL, interleukin; LIF, leukemia inhibitory factor; Ln-332, laminin-332; miRNA, microRNA; MMP, matrix metalloproteinase; MSC, mesenchymal stem cell; NDRG2, N-myc downstream-regulated gene 2; TAM, tumor-associated macrophage; TET1, ten-eleven translocation 1; TNF-, tumor necrosis factor-alpha; YAP1, yes-associated protein 1.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d58620e1 class=n-a></a><h2 class=main-title id=d58897>Competing interests</h2><p class=metadata-entry><a name=d58620e186 class=n-a></a><p id=d58620e187> The authors declare that they have no competing interests.</p></p></div><div class=back-section><a name=d58620e1 class=n-a></a><h2 class=main-title id=d58899>Grant information</h2><p>Portions of this work were supported by (i) a VA Merit Award (1I01BX003031) from the US Department of Veterans Affairs, Biomedical Laboratory Research and Development Service and (ii) the National Institute of Health National Institute of Diabetes and Digestive and Kidney Diseases (DK108959). This material is the result of work supported with resources and the use of facilities at the Central Texas Veterans Health Care System (Temple, TX, USA). The content is the responsibility of the authors alone and does not necessarily reflect the views or policies of the Department of Veterans Affairs or the US Government.</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d58620e799 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d59212>References</h2><div class="section ref-list"><a name=d58620e799 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727401991"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e806 class=n-a></a>Oliveira IS, Kilcoyne A, Everett JM, <i> et al.</i>: Cholangiocarcinoma: classification, diagnosis, staging, imaging features, and management. <i>Abdom Radiol (NY).</i> 2017; <b>42</b>(6): 163749. <a target=xrefwindow id=d58620e817 href="http://www.ncbi.nlm.nih.gov/pubmed/28271275">PubMed Abstract </a> | <a target=xrefwindow id=d58620e820 href="http://dx.doi.org/10.1007/s00261-017-1094-7">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727401991">F1000 Recommendation</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d58620e833 class=n-a></a>Razumilava N, Gores GJ: Combination of gemcitabine and cisplatin for biliary tract cancer: a platform to build on. <i>J Hepatol.</i> 2011; <b>54</b>(3): 5778. <a target=xrefwindow id=d58620e841 href="http://www.ncbi.nlm.nih.gov/pubmed/21112109">PubMed Abstract </a> | <a target=xrefwindow id=d58620e844 href="http://dx.doi.org/10.1016/j.jhep.2010.10.010">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d58620e853 class=n-a></a>Cardinale V, Bragazzi MC, Carpino G, <i> et al.</i>: Cholangiocarcinoma: increasing burden of classifications. <i>Hepatobiliary Surg Nutr.</i> 2013; <b>2</b>(5): 27280. <a target=xrefwindow id=d58620e864 href="http://www.ncbi.nlm.nih.gov/pubmed/24570958">PubMed Abstract </a> | <a target=xrefwindow id=d58620e867 href="http://dx.doi.org/10.3978/j.issn.2304-3881.2013.10.02">Publisher Full Text </a> | <a target=xrefwindow id=d58620e871 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3924690">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731383093"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e880 class=n-a></a>Banales JM, Cardinale V, Carpino G, <i> et al.</i>: Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). <i>Nat Rev Gastroenterol Hepatol.</i> 2016; <b>13</b>(5): 26180. <a target=xrefwindow id=d58620e891 href="http://www.ncbi.nlm.nih.gov/pubmed/27095655">PubMed Abstract </a> | <a target=xrefwindow id=d58620e894 href="http://dx.doi.org/10.1038/nrgastro.2016.51">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731383093">F1000 Recommendation</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d58620e907 class=n-a></a>Bridgewater J, Galle PR, Khan SA, <i> et al.</i>: Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. <i>J Hepatol.</i> 2014; <b>60</b>(6): 126889. <a target=xrefwindow id=d58620e918 href="http://www.ncbi.nlm.nih.gov/pubmed/24681130">PubMed Abstract </a> | <a target=xrefwindow id=d58620e921 href="http://dx.doi.org/10.1016/j.jhep.2014.01.021">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d58620e931 class=n-a></a>Guglielmi A, Ruzzenente A, Campagnaro T, <i> et al.</i>: Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. <i>World J Surg.</i> 2009; <b>33</b>(6): 124754. <a target=xrefwindow id=d58620e942 href="http://www.ncbi.nlm.nih.gov/pubmed/19294467">PubMed Abstract </a> | <a target=xrefwindow id=d58620e945 href="http://dx.doi.org/10.1007/s00268-009-9970-0">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727798428"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e954 class=n-a></a>Si A, Li J, Xiang H, <i> et al.</i>: Actual over 10-year survival after liver resection for patients with intrahepatic cholangiocarcinoma. <i>Oncotarget.</i> 2017; <b>8</b>(27): 4452132. <a target=xrefwindow id=d58620e965 href="http://www.ncbi.nlm.nih.gov/pubmed/28562348">PubMed Abstract </a> | <a target=xrefwindow id=d58620e968 href="http://dx.doi.org/10.18632/oncotarget.17815">Publisher Full Text </a> | <a target=xrefwindow id=d58620e972 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5546499">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727798428">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730366454"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e985 class=n-a></a>Elshamy M, Presser N, Hammad AY, <i> et al.</i>: Liver transplantation in patients with incidental hepatocellular carcinoma/cholangiocarcinoma and intrahepatic cholangiocarcinoma: a single-center experience. <i>Hepatobiliary Pancreat Dis Int.</i> 2017; <b>16</b>(3): 26470. <a target=xrefwindow id=d58620e996 href="http://www.ncbi.nlm.nih.gov/pubmed/28603094">PubMed Abstract </a> | <a target=xrefwindow id=d58620e999 href="http://dx.doi.org/10.1016/S1499-3872(17)60016-X">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730366454">F1000 Recommendation</a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d58620e1012 class=n-a></a>DeOliveira ML, Cunningham SC, Cameron JL, <i> et al.</i>: Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. <i>Ann Surg.</i> 2007; <b>245</b>(5): 75562. <a target=xrefwindow id=d58620e1023 href="http://www.ncbi.nlm.nih.gov/pubmed/17457168">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1026 href="http://dx.doi.org/10.1097/01.sla.0000251366.62632.d3">Publisher Full Text </a> | <a target=xrefwindow id=d58620e1030 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1877058">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d58620e1039 class=n-a></a>Darwish Murad S, Kim WR, Harnois DM, <i> et al.</i>: Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. <i>Gastroenterology.</i> 2012; <b>143</b>(1): 8898.e3; quiz e14. <a target=xrefwindow id=d58620e1050 href="http://www.ncbi.nlm.nih.gov/pubmed/22504095">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1053 href="http://dx.doi.org/10.1053/j.gastro.2012.04.008">Publisher Full Text </a> | <a target=xrefwindow id=d58620e1057 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3846443">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d58620e1066 class=n-a></a>Deviere J, Baize M, de Toeuf J, <i> et al.</i>: Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage. <i>Gastrointest Endosc.</i> 1988; <b>34</b>(2): 95101. <a target=xrefwindow id=d58620e1077 href="http://www.ncbi.nlm.nih.gov/pubmed/2835282">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1080 href="http://dx.doi.org/10.1016/S0016-5107(88)71271-7">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725750286"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e1090 class=n-a></a>Bhat M, Hathcock M, Kremers WK, <i> et al.</i>: Portal vein encasement predicts neoadjuvant therapy response in liver transplantation for perihilar cholangiocarcinoma protocol. <i>Transpl Int.</i> 2015; <b>28</b>(12): 138391. <a target=xrefwindow id=d58620e1101 href="http://www.ncbi.nlm.nih.gov/pubmed/26183487">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1104 href="http://dx.doi.org/10.1111/tri.12640">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725750286">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1598956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e1117 class=n-a></a>van der Gaag NA, Rauws EA, van Eijck CH, <i> et al.</i>: Preoperative biliary drainage for cancer of the head of the pancreas. <i>N Engl J Med.</i> 2010; <b>362</b>(2): 12937. <a target=xrefwindow id=d58620e1128 href="http://www.ncbi.nlm.nih.gov/pubmed/20071702">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1131 href="http://dx.doi.org/10.1056/NEJMoa0903230">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1598956">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d58620e1144 class=n-a></a>Brivio S, Cadamuro M, Strazzabosco M, <i> et al.</i>: Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness. <i>World J Hepatol.</i> 2017; <b>9</b>(9): 45568. <a target=xrefwindow id=d58620e1155 href="http://www.ncbi.nlm.nih.gov/pubmed/28396716">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1158 href="http://dx.doi.org/10.4254/wjh.v9.i9.455">Publisher Full Text </a> | <a target=xrefwindow id=d58620e1162 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5368623">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718475943"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e1171 class=n-a></a>Pattabiraman DR, Weinberg RA: Tackling the cancer stem cells - what challenges do they pose? <i>Nat Rev Drug Discov.</i> 2014; <b>13</b>(7): 497512. <a target=xrefwindow id=d58620e1179 href="http://www.ncbi.nlm.nih.gov/pubmed/24981363">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1182 href="http://dx.doi.org/10.1038/nrd4253">Publisher Full Text </a> | <a target=xrefwindow id=d58620e1185 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4234172">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718475943">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725779842"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e1198 class=n-a></a>Romano M, De Francesco F, Gringeri E, <i> et al.</i>: Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects? <i>J Cell Physiol.</i> 2016; <b>231</b>(4): 76876. <a target=xrefwindow id=d58620e1209 href="http://www.ncbi.nlm.nih.gov/pubmed/26357947">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1212 href="http://dx.doi.org/10.1002/jcp.25190">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725779842">F1000 Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718875911"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e1225 class=n-a></a>Raggi C, Invernizzi P, Andersen JB: Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts. <i>J Hepatol.</i> 2015; <b>62</b>(1): 198207. <a target=xrefwindow id=d58620e1233 href="http://www.ncbi.nlm.nih.gov/pubmed/25220250">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1236 href="http://dx.doi.org/10.1016/j.jhep.2014.09.007">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718875911">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/11184956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e1250 class=n-a></a>Marquardt JU, Raggi C, Andersen JB, <i> et al.</i>: Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways. <i>Hepatology.</i> 2011; <b>54</b>(3): 103142. <a target=xrefwindow id=d58620e1261 href="http://www.ncbi.nlm.nih.gov/pubmed/21618577">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1264 href="http://dx.doi.org/10.1002/hep.24454">Publisher Full Text </a> | <a target=xrefwindow id=d58620e1268 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3179780">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/11184956">F1000 Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d58620e1281 class=n-a></a>Ma S, Chan KW, Hu L, <i> et al.</i>: Identification and characterization of tumorigenic liver cancer stem/progenitor cells. <i>Gastroenterology.</i> 2007; <b>132</b>(7): 254256. <a target=xrefwindow id=d58620e1292 href="http://www.ncbi.nlm.nih.gov/pubmed/17570225">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1295 href="http://dx.doi.org/10.1053/j.gastro.2007.04.025">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d58620e1304 class=n-a></a>Raggi C, Factor VM, Seo D, <i> et al.</i>: Epigenetic reprogramming modulates malignant properties of human liver cancer. <i>Hepatology.</i> 2014; <b>59</b>(6): 225162. <a target=xrefwindow id=d58620e1315 href="http://www.ncbi.nlm.nih.gov/pubmed/24449497">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1318 href="http://dx.doi.org/10.1002/hep.27026">Publisher Full Text </a> | <a target=xrefwindow id=d58620e1322 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4043911">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1120228"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e1331 class=n-a></a>Yamashita T, Forgues M, Wang W, <i> et al.</i>: EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. <i>Cancer Res.</i> 2008; <b>68</b>(5): 145161. <a target=xrefwindow id=d58620e1342 href="http://www.ncbi.nlm.nih.gov/pubmed/18316609">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1345 href="http://dx.doi.org/10.1158/0008-5472.CAN-07-6013">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1120228">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726713762"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e1358 class=n-a></a>Raggi C, Correnti M, Sica A, <i> et al.</i>: Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages. <i>J Hepatol.</i> 2017; <b>66</b>(1): 10215. <a target=xrefwindow id=d58620e1369 href="http://www.ncbi.nlm.nih.gov/pubmed/27593106">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1372 href="http://dx.doi.org/10.1016/j.jhep.2016.08.012">Publisher Full Text </a> | <a target=xrefwindow id=d58620e1376 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5522599">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726713762">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d58620e1389 class=n-a></a>Kallis YN, Robson AJ, Fallowfield JA, <i> et al.</i>: Remodelling of extracellular matrix is a requirement for the hepatic progenitor cell response. <i>Gut.</i> 2011; <b>60</b>(4): 52533. <a target=xrefwindow id=d58620e1400 href="http://www.ncbi.nlm.nih.gov/pubmed/21106552">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1403 href="http://dx.doi.org/10.1136/gut.2010.224436">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d58620e1413 class=n-a></a>Lorenzini S, Bird TG, Boulter L, <i> et al.</i>: Characterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver. <i>Gut.</i> 2010; <b>59</b>(5): 64554. <a target=xrefwindow id=d58620e1424 href="http://www.ncbi.nlm.nih.gov/pubmed/20427399">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1427 href="http://dx.doi.org/10.1136/gut.2009.182345">Publisher Full Text </a> | <a target=xrefwindow id=d58620e1431 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3034133">Free Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718078724"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e1440 class=n-a></a>Govaere O, Komuta M, Berkers J, <i> et al.</i>: Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. <i>Gut.</i> 2014; <b>63</b>(4): 67485. <a target=xrefwindow id=d58620e1451 href="http://www.ncbi.nlm.nih.gov/pubmed/23958557">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1454 href="http://dx.doi.org/10.1136/gutjnl-2012-304351">Publisher Full Text </a> | <a target=xrefwindow id=d58620e1458 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3963546">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718078724">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d58620e1471 class=n-a></a>Sulpice L, Rayar M, Desille M, <i> et al.</i>: Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma. <i>Hepatology.</i> 2013; <b>58</b>(6): 19922000. <a target=xrefwindow id=d58620e1482 href="http://www.ncbi.nlm.nih.gov/pubmed/23775819">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1485 href="http://dx.doi.org/10.1002/hep.26577">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d58620e1494 class=n-a></a>Giannelli G, Fransvea E, Bergamini C, <i> et al.</i>: Laminin-5 chains are expressed differentially in metastatic and nonmetastatic hepatocellular carcinoma. <i>Clin Cancer Res.</i> 2003; <b>9</b>(10 Pt 1): 368491. <a target=xrefwindow id=d58620e1505 href="http://www.ncbi.nlm.nih.gov/pubmed/14506159">PubMed Abstract </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725957458"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e1514 class=n-a></a>Govaere O, Wouters J, Petz M, <i> et al.</i>: Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche. <i>J Hepatol.</i> 2016; <b>64</b>(3): 60917. <a target=xrefwindow id=d58620e1525 href="http://www.ncbi.nlm.nih.gov/pubmed/26592953">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1528 href="http://dx.doi.org/10.1016/j.jhep.2015.11.011">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725957458">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d58620e1541 class=n-a></a>Karp JM, Leng Teo GS: Mesenchymal stem cell homing: the devil is in the details. <i>Cell Stem Cell.</i> 2009; <b>4</b>(3): 20616. <a target=xrefwindow id=d58620e1549 href="http://www.ncbi.nlm.nih.gov/pubmed/19265660">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1552 href="http://dx.doi.org/10.1016/j.stem.2009.02.001">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d58620e1562 class=n-a></a>Chamberlain G, Fox J, Ashton B, <i> et al.</i>: Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. <i>Stem Cells.</i> 2007; <b>25</b>(11): 273949. <a target=xrefwindow id=d58620e1573 href="http://www.ncbi.nlm.nih.gov/pubmed/17656645">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1576 href="http://dx.doi.org/10.1634/stemcells.2007-0197">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d58620e1585 class=n-a></a>Spaeth E, Klopp A, Dembinski J, <i> et al.</i>: Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. <i>Gene Ther.</i> 2008; <b>15</b>(10): 7308. <a target=xrefwindow id=d58620e1596 href="http://www.ncbi.nlm.nih.gov/pubmed/18401438">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1599 href="http://dx.doi.org/10.1038/gt.2008.39">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d58620e1608 class=n-a></a>Yagi H, Soto-Gutierrez A, Parekkadan B, <i> et al.</i>: Mesenchymal stem cells: Mechanisms of immunomodulation and homing. <i>Cell Transplant.</i> 2010; <b>19</b>(6): 66779. <a target=xrefwindow id=d58620e1619 href="http://www.ncbi.nlm.nih.gov/pubmed/20525442">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1622 href="http://dx.doi.org/10.3727/096368910X508762">Publisher Full Text </a> | <a target=xrefwindow id=d58620e1626 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2957533">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d58620e1635 class=n-a></a>Spaeth EL, Dembinski JL, Sasser AK, <i> et al.</i>: Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. <i>PLoS One.</i> 2009; <b>4</b>(4): e4992. <a target=xrefwindow id=d58620e1646 href="http://www.ncbi.nlm.nih.gov/pubmed/19352430">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1649 href="http://dx.doi.org/10.1371/journal.pone.0004992">Publisher Full Text </a> | <a target=xrefwindow id=d58620e1653 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2661372">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725742964"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e1662 class=n-a></a>Sawitza I, Kordes C, Gtze S, <i> et al.</i>: Bile acids induce hepatic differentiation of mesenchymal stem cells. <i>Sci Rep.</i> 2015; <b>5</b>: 13320. <a target=xrefwindow id=d58620e1673 href="http://www.ncbi.nlm.nih.gov/pubmed/26304833">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1676 href="http://dx.doi.org/10.1038/srep13320">Publisher Full Text </a> | <a target=xrefwindow id=d58620e1680 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4548444">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725742964">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d58620e1693 class=n-a></a>Keating A: Mesenchymal stromal cells: new directions. <i>Cell Stem Cell.</i> 2012; <b>10</b>(6): 70916. <a target=xrefwindow id=d58620e1701 href="http://www.ncbi.nlm.nih.gov/pubmed/22704511">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1704 href="http://dx.doi.org/10.1016/j.stem.2012.05.015">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13409150"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e1714 class=n-a></a>Nauta AJ, Fibbe WE: Immunomodulatory properties of mesenchymal stromal cells. <i>Blood.</i> 2007; <b>110</b>(10): 3499506. <a target=xrefwindow id=d58620e1722 href="http://www.ncbi.nlm.nih.gov/pubmed/17664353">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1725 href="http://dx.doi.org/10.1182/blood-2007-02-069716">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13409150">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d58620e1738 class=n-a></a>Krampera M, Cosmi L, Angeli R, <i> et al.</i>: Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. <i>Stem Cells.</i> 2006; <b>24</b>(2): 38698. <a target=xrefwindow id=d58620e1749 href="http://www.ncbi.nlm.nih.gov/pubmed/16123384">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1752 href="http://dx.doi.org/10.1634/stemcells.2005-0008">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727739625"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e1761 class=n-a></a>Zhong W, Tong Y, Li Y, <i> et al.</i>: Mesenchymal stem cells in inflammatory microenvironment potently promote metastatic growth of cholangiocarcinoma via activating Akt/NF- B signaling by paracrine CCL5. <i>Oncotarget.</i> 2017; <b>8</b>: 7369373704. <a target=xrefwindow id=d58620e1772 href="http://dx.doi.org/10.18632/oncotarget.17793">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727739625">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d58620e1785 class=n-a></a>Chen DR, Lu DY, Lin HY, <i> et al.</i>: Mesenchymal stem cell-induced doxorubicin resistance in triple negative breast cancer. <i>Biomed Res Int.</i> 2014; <b>2014</b>: 532161. <a target=xrefwindow id=d58620e1796 href="http://www.ncbi.nlm.nih.gov/pubmed/25140317">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1799 href="http://dx.doi.org/10.1155/2014/532161">Publisher Full Text </a> | <a target=xrefwindow id=d58620e1803 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4124237">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725854181"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e1812 class=n-a></a>Wang W, Zhong W, Yuan J, <i> et al.</i>: Involvement of Wnt/-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma. <i>Oncotarget.</i> 2015; <b>6</b>(39): 4227689. <a target=xrefwindow id=d58620e1823 href="http://www.ncbi.nlm.nih.gov/pubmed/26474277">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1826 href="http://dx.doi.org/10.18632/oncotarget.5514">Publisher Full Text </a> | <a target=xrefwindow id=d58620e1830 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4747224">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725854181">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d58620e1843 class=n-a></a>Friedman RC, Farh KK, Burge CB, <i> et al.</i>: Most mammalian mRNAs are conserved targets of microRNAs. <i>Genome Res.</i> 2009; <b>19</b>(1): 92105. <a target=xrefwindow id=d58620e1854 href="http://www.ncbi.nlm.nih.gov/pubmed/18955434">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1857 href="http://dx.doi.org/10.1101/gr.082701.108">Publisher Full Text </a> | <a target=xrefwindow id=d58620e1861 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2612969">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1022084"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e1871 class=n-a></a>Pillai RS, Artus CG, Filipowicz W: Tethering of human Ago proteins to mRNA mimics the miRNA-mediated repression of protein synthesis. <i>RNA.</i> 2004; <b>10</b>(10): 151825. <a target=xrefwindow id=d58620e1879 href="http://www.ncbi.nlm.nih.gov/pubmed/15337849">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1882 href="http://dx.doi.org/10.1261/rna.7131604">Publisher Full Text </a> | <a target=xrefwindow id=d58620e1885 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1370638">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1022084">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d58620e1898 class=n-a></a>Bartel DP: MicroRNAs: target recognition and regulatory functions. <i>Cell.</i> 2009; <b>136</b>(2): 21533. <a target=xrefwindow id=d58620e1906 href="http://www.ncbi.nlm.nih.gov/pubmed/19167326">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1909 href="http://dx.doi.org/10.1016/j.cell.2009.01.002">Publisher Full Text </a> | <a target=xrefwindow id=d58620e1912 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3794896">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726778314"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e1921 class=n-a></a>Katsumi T, Ninomiya M, Nishina T, <i> et al.</i>: MiR-139-5p is associated with inflammatory regulation through c-FOS suppression, and contributes to the progression of primary biliary cholangitis. <i>Lab Invest.</i> 2016; <b>96</b>(11): 116577. <a target=xrefwindow id=d58620e1932 href="http://www.ncbi.nlm.nih.gov/pubmed/27668889">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1935 href="http://dx.doi.org/10.1038/labinvest.2016.95">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726778314">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d58620e1948 class=n-a></a>Francis H, McDaniel K, Han Y, <i> et al.</i>: Regulation of the extrinsic apoptotic pathway by microRNA-21 in alcoholic liver injury. <i>J Biol Chem.</i> 2014; <b>289</b>(40): 2752639. <a target=xrefwindow id=d58620e1959 href="http://www.ncbi.nlm.nih.gov/pubmed/25118289">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1962 href="http://dx.doi.org/10.1074/jbc.M114.602383">Publisher Full Text </a> | <a target=xrefwindow id=d58620e1966 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4183793">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d58620e1975 class=n-a></a>Kennedy LL, Meng F, Venter JK, <i> et al.</i>: Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice. <i>Lab Invest.</i> 2016; <b>96</b>(12): 125667. <a target=xrefwindow id=d58620e1986 href="http://www.ncbi.nlm.nih.gov/pubmed/27775690">PubMed Abstract </a> | <a target=xrefwindow id=d58620e1989 href="http://dx.doi.org/10.1038/labinvest.2016.112">Publisher Full Text </a> | <a target=xrefwindow id=d58620e1993 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5121007">Free Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d58620e2002 class=n-a></a>Shibata C, Otsuka M, Kishikawa T, <i> et al.</i>: Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinoma. <i>Mol Cell Ther.</i> 2013; <b>1</b>: 5. <a target=xrefwindow id=d58620e2013 href="http://www.ncbi.nlm.nih.gov/pubmed/26056570">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2016 href="http://dx.doi.org/10.1186/2052-8426-1-5">Publisher Full Text </a> | <a target=xrefwindow id=d58620e2020 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4448951">Free Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d58620e2030 class=n-a></a>Baek J, Kang S, Min H: MicroRNA-targeting therapeutics for hepatitis C. <i>Arch Pharm Res.</i> 2014; <b>37</b>(3): 299305. <a target=xrefwindow id=d58620e2038 href="http://www.ncbi.nlm.nih.gov/pubmed/24385319">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2041 href="http://dx.doi.org/10.1007/s12272-013-0318-9">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726400812"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e2050 class=n-a></a>Palumbo T, Poultsides GA, Kouraklis G, <i> et al.</i>: A functional microRNA library screen reveals miR-410 as a novel anti-apoptotic regulator of cholangiocarcinoma. <i>BMC Cancer.</i> 2016; <b>16</b>(1): 353. <a target=xrefwindow id=d58620e2061 href="http://www.ncbi.nlm.nih.gov/pubmed/27259577">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2064 href="http://dx.doi.org/10.1186/s12885-016-2384-0">Publisher Full Text </a> | <a target=xrefwindow id=d58620e2068 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4893280">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726400812">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d58620e2081 class=n-a></a>Haga H, Yan I, Takahashi K, <i> et al.</i>: Emerging insights into the role of microRNAs in the pathogenesis of cholangiocarcinoma. <i>Gene Expr.</i> 2014; <b>16</b>(2): 939. <a target=xrefwindow id=d58620e2092 href="http://www.ncbi.nlm.nih.gov/pubmed/24801170">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2095 href="http://dx.doi.org/10.3727/105221614X13919976902174">Publisher Full Text </a> | <a target=xrefwindow id=d58620e2099 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4166576">Free Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727205811"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e2108 class=n-a></a>Ehrlich L, Hall C, Venter J, <i> et al.</i>: miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation. <i>Am J Pathol.</i> 2017; <b>187</b>(3): 57080. <a target=xrefwindow id=d58620e2119 href="http://www.ncbi.nlm.nih.gov/pubmed/28087162">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2122 href="http://dx.doi.org/10.1016/j.ajpath.2016.10.021">Publisher Full Text </a> | <a target=xrefwindow id=d58620e2126 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5389363">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727205811">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d58620e2139 class=n-a></a>Du K, Li Z, Fang X, <i> et al.</i>: Ferulic acid promotes osteogenesis of bone marrow-derived mesenchymal stem cells by inhibiting microRNA-340 to induce -catenin expression through hypoxia. <i>Eur J Cell Biol.</i> 2017; <b>96</b>(6): 496503. <a target=xrefwindow id=d58620e2150 href="http://www.ncbi.nlm.nih.gov/pubmed/28764862">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2153 href="http://dx.doi.org/10.1016/j.ejcb.2017.07.002">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727851155"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e2162 class=n-a></a>Pakravan K, Babashah S, Sadeghizadeh M, <i> et al.</i>: MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses <i>in vitro</i> angiogenesis through modulating the mTOR/HIF-1/VEGF signaling axis in breast cancer cells. <i>Cell Oncol (Dordr).</i> 2017; <b>40</b>(5): 457470. <a target=xrefwindow id=d58620e2176 href="http://www.ncbi.nlm.nih.gov/pubmed/28741069">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2180 href="http://dx.doi.org/10.1007/s13402-017-0335-7">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727851155">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727753247"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e2194 class=n-a></a>Yu M, Xue Y, Zheng J, <i> et al.</i>: Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway. <i>Mol Cancer.</i> 2017; <b>16</b>(1): 110. <a target=xrefwindow id=d58620e2205 href="http://www.ncbi.nlm.nih.gov/pubmed/28651608">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2208 href="http://dx.doi.org/10.1186/s12943-017-0677-9">Publisher Full Text </a> | <a target=xrefwindow id=d58620e2212 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5485714">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727753247">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d58620e2225 class=n-a></a>Chandrasekharappa SC, Guru SC, Manickam P, <i> et al.</i>: Positional cloning of the gene for multiple endocrine neoplasia-type 1. <i>Science.</i> 1997; <b>276</b>(5311): 4047. <a target=xrefwindow id=d58620e2236 href="http://www.ncbi.nlm.nih.gov/pubmed/9103196">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2239 href="http://dx.doi.org/10.1126/science.276.5311.404">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d58620e2248 class=n-a></a>Vijayaraghavan J, Maggi EC, Crabtree JS: miR-24 regulates menin in the endocrine pancreas. <i>Am J Physiol Endocrinol Metab.</i> 2014; <b>307</b>(1): E8492. <a target=xrefwindow id=d58620e2256 href="http://www.ncbi.nlm.nih.gov/pubmed/24824656">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2259 href="http://dx.doi.org/10.1152/ajpendo.00542.2013">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d58620e2268 class=n-a></a>Meng FL, Wang W, Jia WD: Diagnostic and prognostic significance of serum miR-24-3p in HBV-related hepatocellular carcinoma. <i>Med Oncol.</i> 2014; <b>31</b>(9): 177. <a target=xrefwindow id=d58620e2276 href="http://www.ncbi.nlm.nih.gov/pubmed/25129312">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2279 href="http://dx.doi.org/10.1007/s12032-014-0177-3">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d58620e2288 class=n-a></a>Liu YX, Long XD, Xi ZF, <i> et al.</i>: MicroRNA-24 modulates aflatoxin B1-related hepatocellular carcinoma prognosis and tumorigenesis. <i>Biomed Res Int.</i> 2014; <b>2014</b>: 482926. <a target=xrefwindow id=d58620e2299 href="http://www.ncbi.nlm.nih.gov/pubmed/24800232">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2302 href="http://dx.doi.org/10.1155/2014/482926">Publisher Full Text </a> | <a target=xrefwindow id=d58620e2306 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3997078">Free Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725381434"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e2315 class=n-a></a>Dong W, Li B, Wang Z, <i> et al.</i>: Clinical significance of microRNA-24 expression in esophageal squamous cell carcinoma. <i>Neoplasma.</i> 2015; <b>62</b>(2): 2508. <a target=xrefwindow id=d58620e2326 href="http://www.ncbi.nlm.nih.gov/pubmed/25591590">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2329 href="http://dx.doi.org/10.4149/neo_2015_030">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725381434">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d58620e2343 class=n-a></a>Lee SH, Chen TY, Dhar SS, <i> et al.</i>: A feedback loop comprising PRMT7 and miR-24-2 interplays with Oct4, Nanog, Klf4 and c-Myc to regulate stemness. <i>Nucleic Acids Res.</i> 2016; <b>44</b>(22): 1060318. <a target=xrefwindow id=d58620e2354 href="http://www.ncbi.nlm.nih.gov/pubmed/27625395">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2357 href="http://dx.doi.org/10.1093/nar/gkw788">Publisher Full Text </a> | <a target=xrefwindow id=d58620e2361 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5159542">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d58620e2370 class=n-a></a>Balsalobre A, Damiola F, Schibler U: A serum shock induces circadian gene expression in mammalian tissue culture cells. <i>Cell.</i> 1998; <b>93</b>(6): 92937. <a target=xrefwindow id=d58620e2378 href="http://www.ncbi.nlm.nih.gov/pubmed/9635423">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2381 href="http://dx.doi.org/10.1016/S0092-8674(00)81199-X">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d58620e2390 class=n-a></a>Filipski E, King VM, Li X, <i> et al.</i>: Host circadian clock as a control point in tumor progression. <i>J Natl Cancer Inst.</i> 2002; <b>94</b>(9): 6907. <a target=xrefwindow id=d58620e2401 href="http://www.ncbi.nlm.nih.gov/pubmed/11983758">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2404 href="http://dx.doi.org/10.1093/jnci/94.9.690">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d58620e2413 class=n-a></a>Viswanathan AN, Schernhammer ES: Circulating melatonin and the risk of breast and endometrial cancer in women. <i>Cancer Lett.</i> 2009; <b>281</b>(1): 17. <a target=xrefwindow id=d58620e2421 href="http://www.ncbi.nlm.nih.gov/pubmed/19070424">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2424 href="http://dx.doi.org/10.1016/j.canlet.2008.11.002">Publisher Full Text </a> | <a target=xrefwindow id=d58620e2427 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2735793">Free Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d58620e2436 class=n-a></a>Han Y, Meng F, Venter J, <i> et al.</i>: miR-34a-dependent overexpression of <i>Per1</i> decreases cholangiocarcinoma growth. <i>J Hepatol.</i> 2016; <b>64</b>(6): 1295304. <a target=xrefwindow id=d58620e2450 href="http://www.ncbi.nlm.nih.gov/pubmed/26923637">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2454 href="http://dx.doi.org/10.1016/j.jhep.2016.02.024">Publisher Full Text </a> | <a target=xrefwindow id=d58620e2457 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4874896">Free Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726060990"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e2466 class=n-a></a>Boucher H, Vanneaux V, Domet T, <i> et al.</i>: Circadian Clock Genes Modulate Human Bone Marrow Mesenchymal Stem Cell Differentiation, Migration and Cell Cycle. <i>PLoS One.</i> 2016; <b>11</b>(1): e0146674. <a target=xrefwindow id=d58620e2477 href="http://www.ncbi.nlm.nih.gov/pubmed/26741371">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2480 href="http://dx.doi.org/10.1371/journal.pone.0146674">Publisher Full Text </a> | <a target=xrefwindow id=d58620e2484 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4704833">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726060990">F1000 Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d58620e2498 class=n-a></a>Dawson MA, Kouzarides T: Cancer epigenetics: from mechanism to therapy. <i>Cell.</i> 2012; <b>150</b>(1): 1227. <a target=xrefwindow id=d58620e2506 href="http://www.ncbi.nlm.nih.gov/pubmed/22770212">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2509 href="http://dx.doi.org/10.1016/j.cell.2012.06.013">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d58620e2518 class=n-a></a>You JS, Jones PA: Cancer genetics and epigenetics: two sides of the same coin? <i>Cancer Cell.</i> 2012; <b>22</b>(1): 920. <a target=xrefwindow id=d58620e2526 href="http://www.ncbi.nlm.nih.gov/pubmed/22789535">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2529 href="http://dx.doi.org/10.1016/j.ccr.2012.06.008">Publisher Full Text </a> | <a target=xrefwindow id=d58620e2532 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3396881">Free Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d58620e2541 class=n-a></a>Sandhu DS, Shire AM, Roberts LR: Epigenetic DNA hypermethylation in cholangiocarcinoma: potential roles in pathogenesis, diagnosis and identification of treatment targets. <i>Liver Int.</i> 2008; <b>28</b>(1): 1227. <a target=xrefwindow id=d58620e2549 href="http://www.ncbi.nlm.nih.gov/pubmed/18031477">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2552 href="http://dx.doi.org/10.1111/j.1478-3231.2007.01624.x">Publisher Full Text </a> | <a target=xrefwindow id=d58620e2555 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2904912">Free Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727304177"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e2564 class=n-a></a>Li H, Zhou ZQ, Yang ZR, <i> et al.</i>: MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma. <i>Hepatology.</i> 2017; <b>66</b>(1): 13651. <a target=xrefwindow id=d58620e2575 href="http://www.ncbi.nlm.nih.gov/pubmed/28194813">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2578 href="http://dx.doi.org/10.1002/hep.29116">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727304177">F1000 Recommendation</a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/720027441"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e2591 class=n-a></a>Xu W, Ji J, Xu Y, <i> et al.</i>: MicroRNA-191, by promoting the EMT and increasing CSC-like properties, is involved in neoplastic and metastatic properties of transformed human bronchial epithelial cells. <i>Mol Carcinog.</i> 2015; <b>54 Suppl 1</b>: E14861. <a target=xrefwindow id=d58620e2602 href="http://www.ncbi.nlm.nih.gov/pubmed/25252218">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2605 href="http://dx.doi.org/10.1002/mc.22221">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/720027441">F1000 Recommendation</a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d58620e2618 class=n-a></a>Lee DC, Kang YK, Kim WH, <i> et al.</i>: Functional and clinical evidence for <i>NDRG2</i> as a candidate suppressor of liver cancer metastasis. <i>Cancer Res.</i> 2008; <b>68</b>(11): 421020. <a target=xrefwindow id=d58620e2632 href="http://www.ncbi.nlm.nih.gov/pubmed/18519680">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2636 href="http://dx.doi.org/10.1158/0008-5472.CAN-07-5040">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d58620e2646 class=n-a></a>Tepel M, Roerig P, Wolter M, <i> et al.</i>: Frequent promoter hypermethylation and transcriptional downregulation of the <i>NDRG2</i> gene at 14q11.2 in primary glioblastoma. <i>Int J Cancer.</i> 2008; <b>123</b>(9): 20806. <a target=xrefwindow id=d58620e2660 href="http://www.ncbi.nlm.nih.gov/pubmed/18709645">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2664 href="http://dx.doi.org/10.1002/ijc.23705">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d58620e2673 class=n-a></a>Wang J, Yin D, Xie C, <i> et al.</i>: The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)/gp130/STAT3 pathway. <i>Oncotarget.</i> 2014; <b>5</b>(18): 847891. <a target=xrefwindow id=d58620e2684 href="http://www.ncbi.nlm.nih.gov/pubmed/25261367">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2687 href="http://dx.doi.org/10.18632/oncotarget.2328">Publisher Full Text </a> | <a target=xrefwindow id=d58620e2691 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4226698">Free Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d58620e2700 class=n-a></a>Tong SJ, Liu J, Wang X, <i> et al.</i>: microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression. <i>Exp Ther Med.</i> 2014; <b>8</b>(4): 1296300. <a target=xrefwindow id=d58620e2711 href="http://www.ncbi.nlm.nih.gov/pubmed/25187843">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2714 href="http://dx.doi.org/10.3892/etm.2014.1846">Publisher Full Text </a> | <a target=xrefwindow id=d58620e2718 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4151665">Free Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d58620e2727 class=n-a></a>Swanson JM, Wigal S, Greenhill LL, <i> et al.</i>: Analog classroom assessment of Adderall in children with ADHD. <i>J Am Acad Child Adolesc Psychiatry.</i> 1998; <b>37</b>(5): 51926. <a target=xrefwindow id=d58620e2738 href="http://www.ncbi.nlm.nih.gov/pubmed/9585654">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2741 href="http://dx.doi.org/10.1097/00004583-199805000-00014">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d58620e2750 class=n-a></a>Mansueto G, Forzati F, Ferraro A, <i> et al.</i>: Identification of a New Pathway for Tumor Progression: MicroRNA-181b Up-Regulation and CBX7 Down-Regulation by HMGA1 Protein. <i>Genes Cancer.</i> 2010; <b>1</b>(3): 21024. <a target=xrefwindow id=d58620e2761 href="http://www.ncbi.nlm.nih.gov/pubmed/21779448">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2764 href="http://dx.doi.org/10.1177/1947601910366860">Publisher Full Text </a> | <a target=xrefwindow id=d58620e2768 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3092193">Free Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731383849"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e2777 class=n-a></a>Huang P, Ye B, Yang Y, <i> et al.</i>: MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2. <i>Tumour Biol.</i> 2015; <b>36</b>(5): 33817. <a target=xrefwindow id=d58620e2788 href="http://www.ncbi.nlm.nih.gov/pubmed/25524579">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2791 href="http://dx.doi.org/10.1007/s13277-014-2972-z">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731383849">F1000 Recommendation</a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d58620e2805 class=n-a></a>Conti A, Aguennouz M, La Torre D, <i> et al.</i>: miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors. <i>J Neurooncol.</i> 2009; <b>93</b>(3): 32532. <a target=xrefwindow id=d58620e2816 href="http://www.ncbi.nlm.nih.gov/pubmed/19159078">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2819 href="http://dx.doi.org/10.1007/s11060-009-9797-4">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d58620e2828 class=n-a></a>Pichler M, Winter E, Ress AL, <i> et al.</i>: miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor. <i>J Clin Pathol.</i> 2014; <b>67</b>(3): 198203. <a target=xrefwindow id=d58620e2839 href="http://www.ncbi.nlm.nih.gov/pubmed/24098024">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2842 href="http://dx.doi.org/10.1136/jclinpath-2013-201904">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726647465"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e2851 class=n-a></a>Wang J, Xie C, Pan S, <i> et al.</i>: N-myc downstream-regulated gene 2 inhibits human cholangiocarcinoma progression and is regulated by leukemia inhibitory factor/MicroRNA-181c negative feedback pathway. <i>Hepatology.</i> 2016; <b>64</b>(5): 160622. <a target=xrefwindow id=d58620e2862 href="http://www.ncbi.nlm.nih.gov/pubmed/27533020">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2865 href="http://dx.doi.org/10.1002/hep.28781">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726647465">F1000 Recommendation</a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725258661"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e2878 class=n-a></a>Chatterjee A, Chattopadhyay D, Chakrabarti G: MiR-16 targets Bcl-2 in paclitaxel-resistant lung cancer cells and overexpression of miR-16 along with miR-17 causes unprecedented sensitivity by simultaneously modulating autophagy and apoptosis. <i>Cell Signal.</i> 2015; <b>27</b>(2): 189203. <a target=xrefwindow id=d58620e2886 href="http://www.ncbi.nlm.nih.gov/pubmed/25435430">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2889 href="http://dx.doi.org/10.1016/j.cellsig.2014.11.023">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725258661">F1000 Recommendation</a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726226650"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e2902 class=n-a></a>Tang X, Jin L, Cao P, <i> et al.</i>: MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression. <i>Oncotarget.</i> 2016; <b>7</b>(17): 2366883. <a target=xrefwindow id=d58620e2913 href="http://www.ncbi.nlm.nih.gov/pubmed/26993770">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2916 href="http://dx.doi.org/10.18632/oncotarget.8056">Publisher Full Text </a> | <a target=xrefwindow id=d58620e2920 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5029655">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726226650">F1000 Recommendation</a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d58620e2933 class=n-a></a>Chen L, Wang Q, Wang GD, <i> et al.</i>: miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma. <i>FEBS Lett.</i> 2013; <b>587</b>(9): 136672. <a target=xrefwindow id=d58620e2944 href="http://www.ncbi.nlm.nih.gov/pubmed/23507142">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2947 href="http://dx.doi.org/10.1016/j.febslet.2013.03.007">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d58620e2957 class=n-a></a>Perra A, Kowalik MA, Ghiso E, <i> et al.</i>: YAP activation is an early event and a potential therapeutic target in liver cancer development. <i>J Hepatol.</i> 2014; <b>61</b>(5): 108896. <a target=xrefwindow id=d58620e2968 href="http://www.ncbi.nlm.nih.gov/pubmed/25010260">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2971 href="http://dx.doi.org/10.1016/j.jhep.2014.06.033">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725233286"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e2980 class=n-a></a>Lee K, Lee SS, Kim SB, <i> et al.</i>: Significant association of oncogene YAP1 with poor prognosis and cetuximab resistance in colorectal cancer patients. <i>Clin Cancer Res.</i> 2015; <b>21</b>(2): 35764. <a target=xrefwindow id=d58620e2991 href="http://www.ncbi.nlm.nih.gov/pubmed/25388162">PubMed Abstract </a> | <a target=xrefwindow id=d58620e2994 href="http://dx.doi.org/10.1158/1078-0432.CCR-14-1374">Publisher Full Text </a> | <a target=xrefwindow id=d58620e2998 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4513664">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725233286">F1000 Recommendation</a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d58620e3011 class=n-a></a>Xia Y, Chang T, Wang Y, <i> et al.</i>: YAP promotes ovarian cancer cell tumorigenesis and is indicative of a poor prognosis for ovarian cancer patients. <i>PLoS One.</i> 2014; <b>9</b>(3): e91770. <a target=xrefwindow id=d58620e3022 href="http://www.ncbi.nlm.nih.gov/pubmed/24622501">PubMed Abstract </a> | <a target=xrefwindow id=d58620e3025 href="http://dx.doi.org/10.1371/journal.pone.0091770">Publisher Full Text </a> | <a target=xrefwindow id=d58620e3029 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3951505">Free Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726956163"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e3038 class=n-a></a>Sun D, Li X, He Y, <i> et al.</i>: YAP1 enhances cell proliferation, migration, and invasion of gastric cancer <i>in vitro</i> and <i>in vivo</i>. <i>Oncotarget.</i> 2016; <b>7</b>(49): 8106276. <a target=xrefwindow id=d58620e3056 href="http://www.ncbi.nlm.nih.gov/pubmed/27835600">PubMed Abstract </a> | <a target=xrefwindow id=d58620e3059 href="http://dx.doi.org/10.18632/oncotarget.13188">Publisher Full Text </a> | <a target=xrefwindow id=d58620e3062 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5348376">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726956163">F1000 Recommendation</a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d58620e3075 class=n-a></a>Wu C, Xu B, Yuan P, <i> et al.</i>: Genome-wide interrogation identifies <i>YAP1</i> variants associated with survival of small-cell lung cancer patients. <i>Cancer Res.</i> 2010; <b>70</b>(23): 97219. <a target=xrefwindow id=d58620e3089 href="http://www.ncbi.nlm.nih.gov/pubmed/21118971">PubMed Abstract </a> | <a target=xrefwindow id=d58620e3093 href="http://dx.doi.org/10.1158/0008-5472.CAN-10-1493">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d58620e3102 class=n-a></a>Han S, Wang D, Tang G, <i> et al.</i>: Suppression of miR-16 promotes tumor growth and metastasis through reversely regulating YAP1 in human cholangiocarcinoma. <i>Oncotarget.</i> 2017; <b>8</b>(34): 5663556650. <a target=xrefwindow id=d58620e3113 href="http://www.ncbi.nlm.nih.gov/pubmed/28915618">PubMed Abstract </a> | <a target=xrefwindow id=d58620e3116 href="http://dx.doi.org/10.18632/oncotarget.17832">Publisher Full Text </a> | <a target=xrefwindow id=d58620e3120 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5593589">Free Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/727234701"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d58620e3130 class=n-a></a>Tang Y, Weiss SJ: Snail/Slug-YAP/TAZ complexes cooperatively regulate mesenchymal stem cell function and bone formation. <i>Cell Cycle.</i> 2017; <b>16</b>(5): 399405. <a target=xrefwindow id=d58620e3138 href="http://www.ncbi.nlm.nih.gov/pubmed/28112996">PubMed Abstract </a> | <a target=xrefwindow id=d58620e3141 href="http://dx.doi.org/10.1080/15384101.2017.1280643">Publisher Full Text </a> | <a target=xrefwindow id=d58620e3144 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5351930">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/727234701">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 09 Oct 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1818&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1818&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Internal Medicine, Texas A&amp;M Health Science Center, College of Medicine, Bryan, TX, USA<br/> <sup>2</sup> Research, Central Texas Veterans Health Care System, Temple, TX, USA<br/> <sup>3</sup> Baylor Scott &amp; White Health Digestive Disease Research Center, Temple, TX, USA<br/> <p> <div class=margin-bottom> Lindsey Kennedy <br/> <span>Roles: </span> Conceptualization, Resources, Supervision, Validation, Writing  Review & Editing </div> <div class=margin-bottom> Laura Hargrove <br/> <span>Roles: </span> Conceptualization, Investigation, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Jennifer Demieville <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> Nicole Francis <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> Rowan Seils <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> Sara Villamaria <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> Heather Francis <br/> <span>Roles: </span> Writing  Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-1818/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 09 Oct 2017, 6:1818 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.12118.1">https://doi.org/10.12688/f1000research.12118.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2017 Kennedy L <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=13116 data-id=12118 data-downloads="" data-views="" data-scholar="10.12688/f1000research.12118.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-1818/v1/pdf?article_uuid=e5938888-837a-4e94-9179-7cb26f6856b8" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.12118.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Kennedy L, Hargrove L, Demieville J <em>et al.</em> Recent Advances in Understanding Cholangiocarcinoma [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1818 (<a href="https://doi.org/10.12688/f1000research.12118.1" target=_blank>https://doi.org/10.12688/f1000research.12118.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=12118 id=mobile-track-article-signin-12118 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/12118?target=/articles/6-1818"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=13116 /> <input name=articleId type=hidden value=12118 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Li Wang</strong>, University of Connecticut, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Jesper B Anderson</strong>, University of Copenhagen, Denmark </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 09 Oct 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1818&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1818&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=26935-26798></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=26936-26799></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-1818/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>09 Oct 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Li Wang</strong>, University of Connecticut, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Jesper B Anderson</strong>, University of Copenhagen, Denmark </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-1818&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-1818/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent Advances in Understanding Cholangiocarcinoma".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-1818/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-1818/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-1818/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Kennedy L et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-1818/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-1818",
            templates : {
                twitter : "Recent Advances in Understanding Cholangiocarcinoma. Kennedy L et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-1818/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent Advances in Understanding Cholangiocarcinoma", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent Advances in Understanding Cholangiocarcinoma", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/12118/13116")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "13116");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "26798": 0,
                           "26799": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "66f9a7ed-de92-444a-874a-e8a09eaee3b3";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1818.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1818.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1818.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-1818.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-1818.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>